NKGen Biotech Statistics
Total Valuation
NKGen Biotech has a market cap or net worth of $31.18 million. The enterprise value is $53.11 million.
Market Cap | 31.18M |
Enterprise Value | 53.11M |
Important Dates
The next estimated earnings date is Friday, August 16, 2024, before market open.
Earnings Date | Aug 16, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NKGen Biotech has 25.77 million shares outstanding. The number of shares has increased by 64.77% in one year.
Shares Outstanding | 25.77M |
Shares Change (YoY) | +64.77% |
Shares Change (QoQ) | +42.19% |
Owned by Insiders (%) | 60.49% |
Owned by Institutions (%) | 29.84% |
Float | 6.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -43.95 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -404.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.27M |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NKGen Biotech has paid $7,000 in taxes.
Income Tax | 7,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.29% in the last 52 weeks. The beta is 0.44, so NKGen Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | -88.29% |
50-Day Moving Average | 1.42 |
200-Day Moving Average | 2.56 |
Relative Strength Index (RSI) | 42.85 |
Average Volume (20 Days) | 120,794 |
Short Selling Information
The latest short interest is 520,694, so 2.02% of the outstanding shares have been sold short.
Short Interest | 520,694 |
Short Previous Month | 600,590 |
Short % of Shares Out | 2.02% |
Short % of Float | 7.90% |
Short Ratio (days to cover) | 2.08 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -30.57M |
Pretax Income | -80.01M |
Net Income | -80.01M |
EBITDA | -76.74M |
EBIT | -78.23M |
Earnings Per Share (EPS) | -$4.65 |
Balance Sheet
The company has $284,000 in cash and $22.21 million in debt, giving a net cash position of -$21.93 million or -$0.85 per share.
Cash & Cash Equivalents | 284,000 |
Total Debt | 22.21M |
Net Cash | -21.93M |
Net Cash Per Share | -$0.85 |
Equity (Book Value) | -55.06M |
Book Value Per Share | -2.14 |
Working Capital | -35.88M |
Cash Flow
Operating Cash Flow | -21.07M |
Capital Expenditures | n/a |
Free Cash Flow | -21.07M |
FCF Per Share | -$0.96 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NKGen Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -64.77% |
Shareholder Yield | -64.77% |
Earnings Yield | -256.59% |
FCF Yield | -67.56% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |